Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γSvitlana Demyanets, Johann Wojta, Christoph Kaun et al.|Basic Research in Cardiology|2010Cited by 73
Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidumUlrike Grienke, Judith M. Rollinger, Valery N. Bochkov et al.|Bioorganic & Medicinal Chemistry|2011Cited by 72
Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validationDaniela Schuster, Gerhard Wolber, Patrick Markt et al.|Bioorganic & Medicinal Chemistry|2011Cited by 50
In Human Macrophages the Complement Component C5a Induces the Expression of Oncostatin M via AP-1 ActivationStefan Kastl, Johann Wojta, Walter S. Speidl et al.|Arteriosclerosis Thrombosis and Vascular Biology|2008Cited by 47
Plant extracts in cell-based anti-inflammatory assays—Pitfalls and considerations related to removal of activity masking bulk componentsPaolo Picker, Brigitte Kopp, Sylvia Vogl et al.|Phytochemistry Letters|2014Cited by 11